Latest filing published 04 May 2026 for ExpreS2ion Biotech Holding AB (publ), €14k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Martin Roland Holding ApS: trading record in brief
Filings by Martin Roland Holding ApS span 2 companies, the busiest being ExpreS2ion Biotech Holding AB (publ) and ExpreS2ion Biotech Holding AB. Over a trading history stretching from 2 October 2025 to 30 April 2026, the count stands at 4 filings.
The open-market side counts 1 purchase for €14k alongside 2 sales for €106. On balance, insiders were net buyers of €14k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 1 purchase and 2 sales.
The latest filing, published on 4 May 2026, reports an open-market purchase of €14k in ExpreS2ion Biotech Holding AB (publ). Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. The regulation allows three business days to notify a trade (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin Roland Holding ApS
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 93,750 shares@ SEK 1.60BTU (betald tecknad unit)ISIN SE0028501155FI:csv-0c9dc28ad1dc38871461Canonical exit: 29 Jul 2026 (T+90)
- 334,881 shares@ SEK 0.0028Teckningsrätt/UniträttISIN SE0028501148FI:csv-35189a1cd9fd454dba08
- 113,433 shares@ SEK 0.0018100.0% of flowTeckningsrätt/UniträttISIN SE0019925017FI:A003X786-1
- 2,625 shares@ SEK 14.650.29% mcap100.0% of flowAktieISIN SE0023261292FI:A003S790-1
4 of 4 declarations